Routine detection of acute HIV infection through RNA pooling: Survey of current practice in the United States [1]

Sexually Transmitted Diseases

Volumn 34, Issue 5, 2007, Pages 314-316

  Sherlock, Michelle ^a   Zetola, Nicola M ^b   Klausner, Jeffrey D ^a,b,c  

^a SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; NUCLEIC ACID; RNA;

ALGORITHM; ANTIBODY DETECTION; BLOOD DONOR; BUDGET; COST EFFECTIVENESS ANALYSIS; ENZYME IMMUNOASSAY; FUNDING; GENE POOL; HEALTH CARE COST; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; NUCLEIC ACID AMPLIFICATION; PREVALENCE; QUALITATIVE DIAGNOSIS; QUANTITATIVE DIAGNOSIS; SCREENING TEST; SEXUALLY TRANSMITTED DISEASE; UNITED STATES; VIRUS DETECTION;

DIAGNOSTIC TESTS, ROUTINE; HIV; HIV INFECTIONS; HUMANS; LABORATORIES; MASS SCREENING; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PREDICTIVE VALUE OF TESTS; RNA, VIRAL; UNITED STATES;

EID: 34248177436     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000263262.00273.9c     Document Type: Letter

References (12)

1. Stramer SL, Glynn SA, Kleinman SH, et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med 2004; 351:760-768.
2. Busch MP, Hecht FM. Nucleic acid amplification testing for diagnosis of acute HIV infection: Has the time come? AIDS 2005; 19:1317-1319.
3. Coste J, Reesink HW, Engelfriet CP, et al. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: Update to 2003. Vox Sang 2005; 88:289-303.
4. Tran A. Association of Public Health Laboratories; Personal communication, December 21, 2005.
5. Patel P, Klausner JD, Bacon OM, et al. Detection of acute HIV infections in high-risk patients in California. J Acquir Immun Defic Syndr 2006; 42:75-79.
6. Liska S. Pooled RNA testing of antibody negative high-risk persons: San Francisco and Los Angeles. HIV Diagnostics: New developments and challenges. Orlando, Florida, February 28, 2005.
7. Priddy F, Pilcher C, Moore R, et al. NAAT-based screening for acute HIV infection in an urban HIV counseling and testing population in the southeastern United States. Paper presented at: the 12th Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts, 2005.
8. Shahkolahi AM. Early diagnosis of HIV infection at Whitman Walker clinic STD program using NAATs on pooled blood samples. Presented at: the 2006 National STD Prevention Conference, Jacksonville, Florida, May 2006.
9. Simpson K, Biddle A, Leone PA, et al. Cost effectiveness of screening for acute HIV infection: The North Carolina STAT program. Presented at: the 13th Conference on Retroviruses and Opportunistic Infections, Session 71; 2006. Abstract 374.
10. Weber B. Screening of HIV infection: Role of molecular and immunological assays. Expert Rev Mol Diagn 2006; 6:399-411.
11. Fiebig EW, Wright DJ, Rawal BD, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: Implications for diagnosis and staging of primary HIV infection. AIDS 2003; 17:1871-1879.
12. Marshall DA, Kleinman SH, Wong JB, et al. Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States. Vox Sang 2004; 86:28-40.